| Margins | EBITDA margins compressed by 340 bps YoY to 23.6% (consolidated). |
|---|---|
| Demand visibility | Encouraging customer enquiries suggest sustained demand momentum in coming quarters. |
Growth
Consolidated revenue grew 21% YoY; Domestic up 17%, Exports up 29%. Standalone PAT fell 81% to ₹0.7 cr.
Outlook
New Panchla cell culture lines commissioning by Q2FY27; revenue contribution from new facilities expected to scale in FY28-29.
Risks
High raw material prices due to supply chain disruptions; higher depreciation and finance costs from new facilities.
Last quarter's promises, checked
Delivered
- Guided full commissioning of capex in H1 FY27 → delivered Q2 FY27 timeline (= BEAT)
- Guided domestic business resilience → delivered 17% YoY growth (= BEAT)
- Guided export recovery from Q4 lows → delivered 29% YoY growth (= BEAT)
Partly delivered
- Guided gradual revenue scale-up from new plants → delivered 21% consol growth but PAT fell 81% (= PARTIAL)
Missed
- Guided stable gross margins (71-72%) → delivered 23.6% EBITDA margin with high RM pressure (= MISS)
Investor Presentation filed with BSE, NSE: TARSONS. Summary written with AI assistance from the document.
Tarsons Products Ltd: key numbers
- Share price
- ₹325.10
- Market cap
- ₹1,730 Cr
- Revenue (annual)
- ₹422.5 Cr
- Net profit (annual)
- ₹14.32 Cr
- P/E (TTM)
- 155.9×Sector 54.5×
- Promoter holding
- 47.30%+0.00% QoQ
- FII holding
- 0.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tarsons Products Ltd
All →Tarsons Products Board Meeting Date
Tarsons Products will hold a board meeting on November 12, 2026 to consider unaudited standalone and consolidated half-year results for September 2026. The trading window is closed from October 1 to November 14, 2026.
Tarsons Products Other Announcement
Tarsons Products Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Tarsons Products Management Change
Tarsons Products Limited re-appointed Sanjive Sehgal as Executive Director following his retirement by rotation. This filing updates his directorial status.
Tarsons Products Annual General Meeting
Tarsons Products Limited held its 43rd Annual General Meeting on September 24, 2026, through video conferencing. Shareholders discussed financial statements and approved various resolutions.
Tarsons Products Price Movement Clarification
Tarsons Products clarified that the recent increase in its share trading volume is market-driven, and no undisclosed material information or price-sensitive details exist.
Tarsons Products Other Announcement
Tarsons Products Ltd sent a letter to shareholders without registered emails, providing the web link to access the Annual Report and Notice of the 43rd AGM.